BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7622308)

  • 1. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Lai S; Luna MA; Zhou XD; Weber RS; Goepfert H; Batsakis JG
    Int J Cancer; 1995 Jun; 64(3):196-201. PubMed ID: 7622308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
    Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
    Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
    Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
    Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma.
    Acha-Sagredo A; Ruesga MT; Rodriguez C; Aguirregaviria JI; de Pancorbo MM; Califano JA; Aguirre JM
    Oral Oncol; 2009 Aug; 45(8):661-4. PubMed ID: 19027352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 gene mutations in oral carcinomas from India.
    Munirajan AK; Tutsumi-Ishii Y; Mohanprasad BK; Hirano Y; Munakata N; Shanmugam G; Tsuchida N
    Int J Cancer; 1996 May; 66(3):297-300. PubMed ID: 8621246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the p53 gene in oral squamous-cell carcinomas from Sudanese dippers of nitrosamine-rich toombak and non-snuff-dippers from the Sudan and Scandinavia.
    Ibrahim SO; Vasstrand EN; Johannessen AC; Idris AM; Magnusson B; Nilsen R; Lillehaug JR
    Int J Cancer; 1999 May; 81(4):527-34. PubMed ID: 10225439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of p53 protein is common in premalignant head and neck lesions.
    Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE
    Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of p53 mutations increases with progression of head and neck cancer.
    Boyle JO; Hakim J; Koch W; van der Riet P; Hruban RH; Roa RA; Correo R; Eby YJ; Ruppert JM; Sidransky D
    Cancer Res; 1993 Oct; 53(19):4477-80. PubMed ID: 8402617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases.
    Tjebbes GW; Leppers vd Straat FG; Tilanus MG; Hordijk GJ; Slootweg PJ
    Oral Oncol; 1999 Jul; 35(4):384-9. PubMed ID: 10645403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations in larynx cancer.
    Zhang LF; Hemminki K; Szyfter K; Szyfter W; Söderkvist P
    Carcinogenesis; 1994 Dec; 15(12):2949-51. PubMed ID: 8001261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
    Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
    Nylander K; Nilsson P; Mehle C; Roos G
    Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
    Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
    Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.